Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures
Overview
Neurology
Authors
Affiliations
Background: The Framingham Stroke Risk Profile (FSRP) was created in 1991 to estimate 10-year risk of stroke. It was revised in 2017 (rFSRP) to reflect the modern data on vascular risk factors and stroke risk.
Objective: This study examined the association between the rFSRP and cognitive and brain aging outcomes among participants from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDS).
Methods: Cross-sectional rFSRP was computed at baseline for 19,309 participants (mean age = 72.84, SD = 8.48) from the NACC-UDS [9,697 (50.2%) normal cognition, 4,705 (24.4%) MCI, 4,907 (25.4%) dementia]. Multivariable linear, logistic, or ordinal regressions examined the association between the rFSRP and diagnostic status, neuropsychological test performance, CDR® Sum of Boxes, as well as total brain volume (TBV), hippocampal volume (HCV), and log-transformed white matter hyperintensities (WMH) for an MRI subset (n = 1,196). Models controlled for age, sex, education, racial identity, APOEɛ4 status, and estimated intracranial volume for MRI models.
Results: The mean rFSRP probability was 10.42% (min = 0.50%, max = 95.71%). Higher rFSRP scores corresponded to greater CDR Sum of Boxes (β= 0.02, p = 0.028) and worse performance on: Trail Making Test A (β= 0.05, p < 0.001) and B (β= 0.057, p < 0.001), and Digit Symbol (β= -0.058, p < 0.001). Higher rFSRP scores were associated with increased odds for a greater volume of log-transformed WMH (OR = 1.02 per quartile, p = 0.015). No associations were observed for diagnosis, episodic memory or language test scores, HCV, or TBV.
Conclusion: These results support the rFSRP as a useful metric to facilitate clinical research on the associations between cerebrovascular disease and cognitive and brain aging.
Miner A, Groh J, Tripodis Y, Adler C, Balcer L, Bernick C Alzheimers Dement. 2024; 20(11):7529-7546.
PMID: 39351900 PMC: 11567811. DOI: 10.1002/alz.14231.
Cardiovascular disease risk models and dementia or cognitive decline: a systematic review.
Jia R, Wang Q, Huang H, Yang Y, Chung Y, Liang T Front Aging Neurosci. 2023; 15:1257367.
PMID: 37904838 PMC: 10613491. DOI: 10.3389/fnagi.2023.1257367.
Sun J, Sui Y, Chen Y, Lian J, Wang W Front Neurol. 2023; 14:1264791.
PMID: 37840926 PMC: 10568328. DOI: 10.3389/fneur.2023.1264791.
Morrow C, Leoutsakos J, Yan H, Onyike C, Kamath V J Alzheimers Dis Rep. 2023; 7(1):767-774.
PMID: 37662607 PMC: 10473120. DOI: 10.3233/ADR-230034.